Clinical trials
Recruiting Phase 3 trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 10 |
| 2025 | 23 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| AstraZeneca | 5 |
| Sanofi | 5 |
| GlaxoSmithKline | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Children's Oncology Group | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novo Nordisk A/S | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Heart Failure | 3 |
| Hemophilia A | 3 |
| Hemophilia B | 3 |
| Hemorrhage | 3 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.